Skip to main content
Caplight Logo









NeoMedLight

NeoMedLight

Private
VilleurbanneHealthcare & Life Scienceshttps://www.neomedlight.com/

Last Round

Grant

Oct 25, 2019

Total Funding Raised

$5.02M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NeoMedLight is a therapeutic devices company that develops phototherapy medical devices designed for the prevention and treatment of therapy-induced tissue complications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

phototherapymedical devicesoncology supportive careneonatal carephotobiomodulationlight therapyneonatal jaundiceoral mucositiswoven fiber opticsred light therapylow-level light therapywearable phototherapyLLLTPBMradiodermatitisnon-invasive therapyMedTech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeoMedLight Comparables

Compare NeoMedLight with similar companies based on industry and business-model similarity.

NeoMedLight comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeoLight
78%
GE HealthCare Technologies Inc.
74%
BrainCool AB
71%

NeoMedLight Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 25, 2019
DebtOct 19, 2017
VC RoundApr 8, 2015

Key People

Founding team and executive leadership

Alexandre COUPÉ

CFO Part Time

Executive Team

NeoMedLight Investors

Notable investors and investment history

NeoMedLight investors
InvestorRounds
Smalt CapitalVC Round
Health Angels Rhône-AlpesVC Round
European CommissionGrant
AngelorVC Round
BpifranceDebt
Institut MérieuxVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased from 0 to 2, representing 25% of headcount.

  • Oct 25, 2019

    Secured $2.66M from the European Commission.

NeoMedLight Filings

Explore SEC and related filing metadata, where available.

NeoMedLight filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeoMedLight's valuation, stock price, and market status.

Is NeoMedLight a public or private company?

NeoMedLight is a private company.

What is the current stock price of NeoMedLight?

NeoMedLight is a private company with no public stock price. No recent secondary market data is available.

How much is NeoMedLight worth (valuation)?

Valuation information for NeoMedLight is not publicly available.

Can I buy NeoMedLight stock?

NeoMedLight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeoMedLight's last funding round?

NeoMedLight's most recent funding round was Grant on October 25, 2019.

Who are the main investors in NeoMedLight?

Key investors in NeoMedLight include Smalt Capital, Health Angels Rhône-Alpes, European Commission, Bpifrance, Angelor.

Will NeoMedLight IPO soon?

No public IPO plans have been announced for NeoMedLight.

How can I track NeoMedLight secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeoMedLight's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVilleurbanne
Employee Range5
Year Founded2014
Last FundingOct 25, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?